Proof-of-Concept Development and Preclinical Evaluation of a Microarray Patch Platform for Codelivery of Multiple Broadly Neutralizing Antibodies for HIV Prevention.

Saved in:
Bibliographic Details
Title: Proof-of-Concept Development and Preclinical Evaluation of a Microarray Patch Platform for Codelivery of Multiple Broadly Neutralizing Antibodies for HIV Prevention.
Authors: Peet MM; CONRAD, Macon & Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, Virginia 23507, United States., Agrahari V; CONRAD, Macon & Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, Virginia 23507, United States., Singh P; Department of Biomedical Engineering, University of Connecticut, Storrs, Connecticut 06269, United States., Nguyen LLH; Department of Biomedical Engineering, University of Connecticut, Storrs, Connecticut 06269, United States., Ouattara LA; CONRAD, Macon & Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, Virginia 23507, United States., Yang ES; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20814, United States., Herrera C; CONRAD, Macon & Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, Virginia 23507, United States., Pegu A; VLP Therapeutics, Inc., Gaithersburg, Maryland 20878, United States., Pierson TC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20814, United States., Nguyen TD; Department of Biomedical Engineering, University of Connecticut, Storrs, Connecticut 06269, United States.; Department of Mechanical Engineering, University of Connecticut, Storrs, Connecticut 06269, United States.; Institute of Materials Science, Polymer Program, University of Connecticut, Storrs, Connecticut 06269, United States., Doncel GF; CONRAD, Macon & Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, Virginia 23507, United States.
Source: Molecular pharmaceutics [Mol Pharm] 2026 Jul 14. Date of Electronic Publication: 2026 Jul 14.
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1543-8392
DOI:10.1021/acs.molpharmaceut.5c01650